Demetrix Signs First CMO for Cannabinoid Production February 25, 2021 Contact Author Michele Behrens
Close
Demetrix signs its first contract manufacturing organization for commercial scale production of cannabinoids.
Sponsored
Demetrix, Inc. announced it has signed its first contract manufacturing organization (CMO) partner for the commercial scale production of rare cannabinoids using fermentation.
The unamed CMO partner is an FDA-registered, food cGMP-compliant facility. Through the CMO, Demetrix will be able to produce metric tons of cannabinoids annually while delivering a steady, sustainable stream of safe, high-purity, affordable ingredients for companies. The first ingredient the company plans to bring to market is cannabigerol (CBG).